Evidence map›Paper›PMID 27414758›Full record

ArticleNature protocols2016

Protein-observed (19)F-NMR for fragment screening, affinity quantification and druggability assessment.

Clifford T Gee, Keith E Arntson, Andrew K Urick, Neeraj K Mishra, Laura M L Hawk, Andrea J Wisniewski, William C K Pomerantz

Abstract read
In one paragraph

Article in Nature protocols, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed.

  1. NMR Studies on Protein-Ligand Interactions.International journal of molecular sciences · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Perspectives on Applications ofMolecules (Basel, Switzerland) · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. UsingACS nanoscience Au · 2023
    Article
  13. Review
  14. Article
  15. Development of a single cultureJournal of fluorine chemistry · 2022
    Article
  16. Article
  17. Article
  18. Druggable Allosteric Sites in β-Propeller Lectins.Angewandte Chemie (International ed. in English) · 2022
    Article
  19. RSC chemical biology · 2021
    Review
  20. FastAnalytical chemistry · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Clifford T GeeDepartment of Chemistry, University of Minnesota, Minneapolis, Minnesota, USA.
Keith E ArntsonDepartment of Chemistry, University of Minnesota, Minneapolis, Minnesota, USA.
Andrew K UrickDepartment of Chemistry, University of Minnesota, Minneapolis, Minnesota, USA.
Neeraj K MishraDepartment of Chemistry, University of Minnesota, Minneapolis, Minnesota, USA.
Laura M L HawkDepartment of Chemistry, University of Minnesota, Minneapolis, Minnesota, USA.
Andrea J WisniewskiDepartment of Medicinal Chemistry, University of Minnesota, Minneapolis, Minnesota, USA.
William C K PomerantzDepartment of Chemistry, University of Minnesota, Minneapolis, Minnesota, USA.

Funding

TRAINING FOR FUTURE BIOTECHNOLOGY DEVELOPMENTT32GM008347 · NIGMS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI SCHMIDT-DANNERT, CLAUDIA · 1990 to 2021
$11.0M
Chemistry-Biology Interface Training GrantT32GM008700 · NIGMS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI DISTEFANO, MARK D · 1999 to 2018
$4.0M
NIGMS NIH HHS T32 GM008347NIGMS NIH HHS T32 GM008700
6 · The paper itself

Abstract

NMR spectroscopy can be used to quantify the binding affinity between proteins and low-complexity molecules, termed 'fragments'; this versatile screening approach allows researchers to assess the druggability of new protein targets. Protein-observed (19)F-NMR (PrOF NMR) using (19)F-labeled amino acids generates relatively simple spectra that are able to provide dynamic structural information toward understanding protein folding and function. Changes in these spectra upon the addition of fragment molecules can be observed and quantified. This protocol describes the sequence-selective labeling of three proteins (the first bromodomains of Brd4 and BrdT, and the KIX domain of the CREB-binding protein) using commercially available fluorinated aromatic amino acids and fluorinated precursors as example applications of the method developed by our research group. Fragment-screening approaches are discussed, as well as Kd determination, ligand-efficiency calculations and druggability assessment, i.e., the ability to target these proteins using small-molecule ligands. Experiment times on the order of a few minutes and the simplicity of the NMR spectra obtained make this approach well-suited to the investigation of small- to medium-sized proteins, as well as the screening of multiple proteins in the same experiment.

Indexed as

HalogenationLigandsMagnetic Resonance SpectroscopyModels, MolecularPharmaceutical PreparationsProtein ConformationProteinsLigandsPharmaceutical PreparationsProteins

Identifiers

PMID27414758
PMCPMC8322963

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.